PFIZER : FDA APPROVES CIBINQO FOR ECZEMA

Pfizer announced Friday evening that the Food and Drug Administration (FDA) has approved Cibinqo, a janus kinase (JAK) inhibitor, for the treatment of moderate to severe atop…